Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD

Clinical trial NCT01880788 · COMPLETED

Trial details

NCT number: NCT01880788
Sponsor: Sequenom, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Age Related Macular Degeneration Choroidal Neovascularization Central Serous Chorioretinopathy

Start date: 2012-11-01
Primary completion: 2015-03-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.